MET and gastric cancer: As the gene encoding the hepatocyte growth factor (HGF) receptor, MET, is a transcriptional target of MACC1 [20], the downstream signaling pathway of HGF-c-MET maybe involved in the mechanism of the“MACC1 regulating the resistant to trastuzumab” in gastric cancer cells.